Johnson & Johnson Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Dec '25 Dec 28, 2025	Dec '24 Dec 29, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 2, 2022
Net Income	26,804	14,066	35,153	17,941	20,878
Depreciation & Amortization	7,503	7,339	7,486	6,970	7,390
Share-Based Compensation	1,354	1,176	1,162	1,138	1,135
Other Operating Activities	-11,131	1,685	-21,010	-4,855	-5,993
Operating Cash Flow	24,530	24,266	22,791	21,194	23,410
Operating Cash Flow Growth	1.09%	6.47%	7.54%	-9.47%	-0.53%
Capital Expenditures	-4,832	-4,424	-4,543	-4,009	-3,652
Acquisitions	-17,206	-16,254	-112	-17,109	651
Change in Investments	-1,388	2,253	5,521	8,976	-5,174
Other Investing Activities	-162	-174	12	-229	-508
Investing Cash Flow	-23,588	-18,599	878	-12,371	-8,683
Dividends Paid	-12,381	-11,823	-11,770	-11,682	-11,032
Share Issuance / Repurchase	-2,535	-1,594	-3,960	-4,706	-2,420
Debt Issued / Paid	9,411	10,323	-2,953	7,424	-709
Other Financing Activities	-34	-38	2,858	93	114
Financing Cash Flow	-5,539	-3,132	-15,825	-8,871	-14,047
Exchange Rate Effect	201	-289	-112	-312	-178
Net Cash Flow	-4,396	2,246	7,732	-360	502
Free Cash Flow	19,698	19,842	18,248	17,185	19,758
Free Cash Flow Growth	-0.73%	8.73%	6.19%	-13.02%	-2.14%
Free Cash Flow Margin	20.91%	22.34%	21.43%	21.48%	25.09%
Free Cash Flow Per Share	8.18	8.24	7.20	6.55	7.51

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).